Cayman Islands
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 419.46 M |
Jan. 14, 2025 | USD 8.53 | -0.47% |
|
Cayman Islands |
|
2 |
USD 74.17 M |
Jan. 14, 2025 | USD 2.01 | 1.52% |
|
Cayman Islands |
The Pharmaceuticals company in Cayman Islands with the highest Market Capitalization is Theravance Biopharma, Inc. (NasdaqGM: TBPH) at USD 419.46 M.
The Pharmaceuticals company in Cayman Islands with the lowest Market Capitalization is Adlai Nortye Ltd. American Depositary Shares (NasdaqGM: ANL) at USD 74.17 M.
The top 10 Pharmaceuticals companies in Cayman Islands by Market Capitalization are Theravance Biopharma, Inc. and Adlai Nortye Ltd. American Depositary Shares.
The bottom 10 Pharmaceuticals companies in Cayman Islands by Market Capitalization are Adlai Nortye Ltd. American Depositary Shares and Theravance Biopharma, Inc..